The Pharmacy Times® Immunoglobulins Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.
August 14th 2025
Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.
Cellular Respiration Significantly Increases in Patients with Primary Immunodeficiency Disorders
October 28th 2019Metabolic activity in the immune cells of patients with primary immunodeficiency was used as a biomarker due to cellular metabolism, which serves as a key regulator in immune cells.
Read More
Differentiating Characteristics and Evaluating Intravenous, Subcutaneous Immunoglobulin
October 7th 2019Subcutaneous immunoglobin has increased treatment options for patients with several conditions, such as primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy.
Read More
Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and Costs
April 18th 2016Real-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Read More
Alzheimer's Treatment Study Reports 3 Years With No Decline In Memory And Function At AAIC 2012
July 19th 2012The first report of long-term (3-year) stabilization of Alzheimer's disease symptoms with IVIG, including no decline on measures of cognition, memory, daily functioning and mood, was recently reported at the Alzheimer's Association International Conference 2012 in Vancouver.
Read More